Unlearn AI

Unlearn.AI specializes in using AI to generate synthetic data for clinical trials in the pharmaceutical and healthcare industries.

Headquarters

Year Founded

Company Status

Website

Sector

Operating Status

Social Media

Search Tags

digital twins, AI in healthcare, clinical trial innovation

About Us

Unlearn.AI develops artificial intelligence (AI) technology to create digital twins of clinical trial participants. These digital twins are virtual models that predict patient health outcomes over time. The company uses this technology to streamline and accelerate clinical trials, reducing the number of participants needed in control groups and potentially speeding up the drug development process.

Trending Companies in AI

Latest Articles in AI

Medicare will pilot AI-driven prior authorization in 2026 across six states, targeting high-risk services while clinicians make final decisions.

AI-Powered Prior Authorization Comes to Traditional Medicare

Traditional Medicare will pilot AI-assisted prior authorization in 2026 across six states, focusing on high-risk outpatient services. Clinicians retain final say, but incentives and access concerns loom as CMS tests fraud reduction and “gold card” exemptions. Here’s what providers and patients should know.

Read More >
Anycubic Photon Mono M7 Pro for $469 with code AC30OFF. FREE $99 Gifts: 1*High Speed Resin+2*FEP Film+3000pcs Limited Mystery Box

CREATORS. DISRUPTORS. INNOVATORS.

Discover Emerging Technology Companies